Epidural steroid injection therapy for low back pain: a meta-analysis

Area of Science:

• Pain Management
• Spinal Interventions
• Evidence-Based Medicine

Background:

• Low back pain is a prevalent condition requiring effective long-term treatment strategies.
• Epidural steroid injections (ESIs) are commonly used for managing low back pain.
• The long-term efficacy of ESIs remains a subject of ongoing research and clinical debate.

Purpose of the Study:

• To systematically evaluate the long-term (≥ 6 months) benefits of epidural steroid injection therapies for low back pain.
• To assess the impact of ESIs on pain relief, functional improvement, and subsequent surgery rates.
• To identify potential biases and necessary adjustments in the evaluation of injection therapies.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials (RCTs) with a minimum 6-month follow-up.
• Inclusion of studies identified through comprehensive database and hand searches without language restrictions.
• Analysis of outcomes including pain relief, back-specific disability, and need for surgery, using a random-effects model.

Main Results:

• Twenty-nine RCTs were included in the meta-analysis.
• A statistically significant pain reduction was observed at 6 months, but this effect diminished and was not significant after adjusting for baseline pain scores.
• ESIs did not demonstrate superior improvement in back-specific disability or a significant reduction in subsequent surgery rates compared to placebo or other interventions.

Conclusions:

• The study did not find evidence to support long-term benefits (≥ 6 months) of epidural steroid injections for low back pain.
• Potential selection bias in existing injection studies was identified as a concern.
• Accurate evaluation of pain outcomes necessitates baseline score adjustments in injection therapy research.